Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.

对参与 Muscleblind-like-1 同工型核定位、剪接活性和二聚化的外显子区域进行分析

阅读:4
作者:Tran Hélène, Gourrier Nathalie, Lemercier-Neuillet Camille, Dhaenens Claire-Marie, Vautrin Audrey, Fernandez-Gomez Francisco José, Arandel Ludovic, Carpentier Céline, Obriot Hélène, Eddarkaoui Sabiha, Delattre Lucie, Van Brussels Edwige, Holt Ian, Morris Glenn E, Sablonnière Bernard, Buée Luc, Charlet-Berguerand Nicolas, Schraen-Maschke Susanna, Furling Denis, Behm-Ansmant Isabelle, Branlant Christiane, Caillet-Boudin Marie-Laure, Sergeant Nicolas
Muscleblind-like-1 (MBNL1) is a splicing regulatory factor controlling the fetal-to-adult alternative splicing transitions during vertebrate muscle development. Its capture by nuclear CUG expansions is one major cause for type 1 myotonic dystrophy (DM1). Alternative splicing produces MBNL1 isoforms that differ by the presence or absence of the exonic regions 3, 5, and 7. To understand better their respective roles and the consequences of the deregulation of their expression in DM1, here we studied the respective roles of MBNL1 alternative and constitutive exons. By combining genetics, molecular and cellular approaches, we found that (i) the exon 5 and 6 regions are both needed to control the nuclear localization of MBNL1; (ii) the exon 3 region strongly enhances the affinity of MBNL1 for its pre-mRNA target sites; (iii) the exon 3 and 6 regions are both required for the splicing regulatory activity, and this function is not enhanced by an exclusive nuclear localization of MBNL1; and finally (iv) the exon 7 region enhances MBNL1-MBNL1 dimerization properties. Consequently, the abnormally high inclusion of the exon 5 and 7 regions in DM1 is expected to enhance the potential of MBNL1 of being sequestered with nuclear CUG expansions, which provides new insight into DM1 pathophysiology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。